This site is intended for healthcare professionals

Ep 7 – Appropriate use and safety profile of SGLT2 inhibitors

Dr Kevin Fernando provides a practical overview of the utility of sodium–glucose cotransporter 2 inhibitors, focusing on dosing, cardiovascular and renal safety and the management of adverse events, including dehydration and genital infections.

Share this episode:

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.


Would you like to receive updates about new podcast episodes by email? (You can unsubscribe at any time)